EndeavorRx Marks a Medical Milestone (Image Credits: Unsplash)
United States – Families grappling with pediatric mental health challenges discovered a novel option in 2020 when regulators approved the first video game as a prescription treatment for ADHD.[1]
EndeavorRx Marks a Medical Milestone
Neuroscientists at the University of California, San Francisco developed EndeavorRx, which underwent five clinical trials demonstrating its ability to enhance attention in children with ADHD. Unlike stimulant medications, the game produced these gains without associated side effects. Parents simply downloaded the app to a tablet, allowing their children to engage in targeted play sessions lasting 25 minutes daily. Regulators cleared it as the pioneering video game prescription, signaling a shift toward software-based interventions. Six years later, however, widespread use remained elusive for most American families.
This approval highlighted the potential of digital therapeutics, a category now including nearly 20 FDA-cleared products. Virtual reality neurotherapy emerged alongside it, immersing children in controlled environments to build skills like sustained attention and impulse control. Neuropsychologists designed these tools to adapt via AI, personalizing sessions while standardizing outcomes for clinical validation.[1]
A Mounting Pediatric Mental Health Emergency
One in five American children contended with a mental health condition as the crisis intensified. Teenage depression rates nearly doubled since 2009, while suicide ranked as the second leading cause of death among adolescents. Children in the U.S. consumed more psychiatric drugs than those in any other developed nation, often amid provider shortages and long waitlists. Rural areas, home to 60 million residents, faced acute access issues that rendered traditional therapy impractical. Overdiagnosis and overtreatment plagued the system, according to reports from bodies like the MAHA Commission.
Digital options addressed multiple needs with one device. A 2025 review of 14 studies confirmed VR interventions boosted social skills in children with autism. Separate research on ADHD showed gains in attention accuracy, with fewer errors during tasks. These non-drug approaches sidestepped adherence struggles common in conventional care.[1]
Veterans’ Success Points the Way
The Veterans Health Administration rolled out VR therapy across 165 medical centers in all 50 states, treating PTSD, chronic pain, anxiety, and more than 30 other conditions. This nationwide deployment proved scalable integration of digital tools in public healthcare. Children, facing similar issues like anxiety and neurodivergence, stood to benefit equally from such immersive, distraction-free sessions.
Allan Gobbs, co-founder of ATEM Capital, posed a stark question: “If VR therapy is good enough for American veterans, why isn’t it available to American children?”[1] He observed that stimulants dominated not due to superiority, but because reimbursement systems favored pharmaceuticals exclusively.
Reimbursement Walls and Global Contrasts
Medicare and Medicaid declined coverage for prescription digital therapeutics, prompting private insurers to follow suit. The Congressional Budget Office struggled to estimate costs for the Access to Prescription Digital Therapeutics Act, stalling progress. EndeavorRx’s adoption stayed limited despite FDA validation years earlier. Regulations trailed scientific advances, leaving families with pills or endless waitlists.
- Lack of federal reimbursement sets precedent for private payers.
- Budgetary uncertainties doom legislative efforts.
- Rural access gaps amplify inequities in therapy delivery.
- Slow policy adaptation ignores proven VA and international models.
Germany offered a counterpoint, reimbursing over 50 digital products since 2020 at a cost of €234 million. Recent U.S. moves included a bipartisan reintroduction of the therapeutics act, backed by Senators John Cornyn and Bill Cassidy, along with Robert F. Kennedy Jr. The Centers for Medicare & Medicaid Services also unveiled a $50 billion rural health program emphasizing digital innovations.[1]
Key Takeaways
- FDA-cleared digital therapies like EndeavorRx deliver results without drug side effects, backed by rigorous trials.
- Healthcare payers’ refusal to reimburse perpetuates overmedication amid a youth mental health surge.
- VA’s VR rollout and Germany’s model provide blueprints for equitable access nationwide.
Validated digital therapies awaited deployment, much like tools that transformed veterans’ care. Bridging reimbursement gaps promised to ease emergency room overloads and reduce reliance on medications. Policymakers held the key to equitable delivery. What steps should come next to make these innovations standard for children? Share your thoughts in the comments.
